Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating microRNAs as a Novel Biomarker of Early Cardiotoxicity in Breast Cancer Patients Treated With Anthracyclines

NCT02065908 is registered in ClinicalTrials.gov with West Pomeranian Cancer Center as lead sponsor.

NCT NCT02065908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02065908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating microRNAs as a Novel Biomarker of Early Cardiotoxicity in Breast Cancer Patients Treated With Anthracyclines
Lead sponsor
West Pomeranian Cancer Center
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
December 31, 2016
Enrollment
128 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer